United Therapeutics (UTHR) EPS (Basic) (QoQ) (2009 - 2026)
United Therapeutics (UTHR) EPS (Basic) (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.69% |
| Mar 31, 2026 | -23.15% |
| Dec 31, 2025 | 6.34% |
| Sep 30, 2025 | 12.68% |
| Jun 30, 2025 | -4.37% |
| Mar 31, 2025 | 7.65% |
| Dec 31, 2024 | -3.82% |
| Sep 30, 2024 | 10.65% |
| Jun 30, 2024 | -3.98% |
| Mar 31, 2024 | 40.62% |
| Dec 31, 2023 | -18.70% |
| Sep 30, 2023 | 3.24% |
| Jun 30, 2023 | 6.22% |
| Mar 31, 2023 | 79.21% |
| Dec 31, 2022 | -44.80% |
| Sep 30, 2022 | 105.84% |
| Jun 30, 2022 | -51.86% |
| Mar 31, 2022 | 112.40% |
| Dec 31, 2021 | -31.04% |
| Sep 30, 2021 | -5.95% |